1988 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

Filter
Article

Zoledronic acid exerts its antitumor effect in multiple myeloma interfering with the bone marrow microenvironment

Corso, A., Ferretti, E. & Lazzarino, M., Jun 2005, In : Hematology. 10, 3, p. 215-224 10 p.

Research output: Contribution to journalArticle

Zoledronic acid down-regulates adhesion molecules of bone marrow stromal cells in multiple myeloma: A possible mechanism for its antitumor effect

Corso, A., Ferretti, E., Lunghi, M., Zappasodi, P., Mangiacavalli, S., De Amici, M., Rusconi, C., Varettoni, M. & Lazzarino, M., Jul 1 2005, In : Cancer. 104, 1, p. 118-125 8 p.

Research output: Contribution to journalArticle

Urinary proteins in multiple myeloma: Correlation with clinical parameters and diagnostic implications

Corso, A., Zappasodi, P., Pascutto, C., Bosoni, T., Mangiacavalli, S., Lorenzi, A., Rusconi, C. & Lazzarino, M., Aug 1 2003, In : Annals of Hematology. 82, 8, p. 487-491 5 p.

Research output: Contribution to journalArticle

Urinary proteins and renal dysfunction in patients with multiple myeloma

Corso, A., Zappasodi, P. & Lazzarino, M., 2002, In : Biomedicine and Pharmacotherapy. 56, 3, p. 139-143 5 p.

Research output: Contribution to journalArticle

Transient response of myeloma clone to pamidronate therapy [8]

Corso, A., Astori, C., Orlandi, E., Zappasodi, P., Arcaini, L. & Bemasconi, C., 1999, In : Haematologica. 84, 8, p. 759-760 2 p.

Research output: Contribution to journalArticle

Thrombomodulin levels are not modified during thalidomide treatment

Zappasodi, P., Mangiacavalli, S., Terulla, V., Airò, F., Klersy, C., Varettoni, M. & Corso, A., Nov 2006, In : European Journal of Haematology. 77, 5, p. 453-454 2 p.

Research output: Contribution to journalArticle

The value of combination therapy in adult acute myeloid leukemia with central nervous system involvement

Castagnola, C., Nozza, A., Corso, A. & Bernasconi, C., Sep 1997, In : Haematologica. 82, 5, p. 577-580 4 p.

Research output: Contribution to journalArticle

The VAD-DCEP sequence is an effective pre-transplant therapy in untreated multiple myeloma

Corso, A., Barbarano, L., Zappasodi, P., Cairoli, R., Alessandrino, E. P., Mangiacavalli, S., Ferrari, D., Fava, S., Fiumanò, M., Frigerio, G., Isa, L., Luraschi, A., Klersy, C., De Paoli, A., Vergani, C., Banfi, L., Perego, D., Ucci, G., Pinotti, G., Savarè, M. & 4 others, Uziel, L., Vismara, A., Morra, E. & Lazzarino, M., Sep 2004, In : Haematologica. 89, 9, p. 1124-1127 4 p.

Research output: Contribution to journalArticle

The role of systemic high-dose cytarabine in the treatment of central nervous system leukemia: Clinical results in 46 patients

Morra, E., Lazzarino, M., Brusamolino, E., Pagnucco, G., Castagnola, C., Bernasconi, P., Orlandi, E., Corso, A., Santagostino, A. & Bernasconi, C., 1993, In : Cancer. 72, 2, p. 439-445 7 p.

Research output: Contribution to journalArticle

The possible role of burden of therapy on the risk of myeloma extramedullary spread

Mangiacavalli, S., Pompa, A., Ferretti, V., Klersy, C., Cocito, F., Varettoni, M., Cartia, C. S., Cazzola, M. & Corso, A., Oct 21 2016, (Accepted/In press) In : Annals of Hematology. p. 1-8 8 p.

Research output: Contribution to journalArticle

The possible role of burden of therapy on the risk of myeloma extramedullary spread

Mangiacavalli, S., Pompa, A., Ferretti, V., Klersy, C., Cocito, F., Varettoni, M., Cartia, C. S., Cazzola, M. & Corso, A., Jan 1 2017, In : Annals of Hematology. 96, 1, p. 73-80 8 p.

Research output: Contribution to journalArticle

The place of thalidomide in the treatment of multiple myeloma

Corso, A. & Mangiacavalli, S., Feb 2008, In : Oncology Reviews. 1, 4, p. 205-214 10 p.

Research output: Contribution to journalArticle

The natural history of a solitary plasmacytoma

Corso, A., 2002, In : British Journal of Haematology. 118, 2, p. 350 1 p.

Research output: Contribution to journalArticle

The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity

Oliva, L., Orfanelli, U., Resnati, M., Raimondi, A., Orsi, A., Milan, E., Palladini, G., Milani, P., Cerruti, F., Cascio, P., Casarini, S., Rognoni, P., Touvier, T., Marcatti, M., Ciceri, F., Mangiacavalli, S., Corso, A., Merlini, G. & Cenci, S., 2017, In : Blood. 129, 15, p. 2132-2142 11 p.

Research output: Contribution to journalArticle

The amyloidogenic light chain is a stressor that sensitizes plasma cells to proteasome inhibitor toxicity

Oliva, L., Orfanelli, U., Resnati, M., Raimondi, A., Orsi, A., Milan, E., Palladini, G., Milani, P., Cerruti, F., Cascio, P., Casarini, S., Rognoni, P., Touvier, T., Marcatti, M., Ciceri, F., Mangiacavalli, S., Corso, A., Merlini, G. & Cenci, S., Apr 13 2017, In : Blood. 129, 15, p. 2132-2142 11 p.

Research output: Contribution to journalArticle

The advantages of switch to subcutaneous bortezomib in the real life

Mangiacavalli, S., Cocito, F., Ferretti, V. V., Ganzetti, M., Cartia, C. S. & Corso, A., Jun 2018, In : Leukemia and Lymphoma. 59, 6, p. 1505-1507 3 p.

Research output: Contribution to journalArticle

Thalidomide in refractory myeloma patients: Early changes in bone marrow cellularity

Zappasodi, P., Lorenzi, A. & Corso, A., 2001, In : Haematologica. 86, 4, p. 448 1 p.

Research output: Contribution to journalArticle

Sweet's syndrome and myelodysplasia: Two entities with a common pathogenetic mechanism? A case report

Zappasodi, P., Corso, A. & Del Forno, C., 2000, In : Haematologica. 85, 8, p. 868-869 2 p.

Research output: Contribution to journalArticle

Successful therapy with high-dose steroids and cyclosporine for the treatment of carmustine-mediated lung injury

Zappasodi, P., Vitulo, P., Volpini, E., Castagnola, C., Nascimbene, C. & Corso, A., 2002, In : Annals of Hematology. 81, 6, p. 347-349 3 p.

Research output: Contribution to journalArticle

Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice: Leukemia and Lymphoma

Cocito, F., Mangiacavalli, S., Ferretti, V. V., Cartia, C. S., Ganzetti, M., Benveuti, P., Pompa, A., Catalano, M., Fugazza, E., Landini, B., Arcaini, L. & Corso, A., 2019, In : Leuk. Lymphoma. 60, 12, p. 2968-2974 7 p.

Research output: Contribution to journalArticle

Smoldering multiple myeloma: the role of different scoring systems in identifying high-risk patients in real-life practice

Cocito, F., Mangiacavalli, S., Valeria Ferretti, V., Cartia, C. S., Ganzetti, M., Benveuti, P., Pompa, A., Catalano, M., Fugazza, E., Landini, B., Arcaini, L. & Corso, A., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

Similar neurotoxicity of an alternating compared to a continuous low-dose schedule of thalidomide for relapsed/refractory multiple myeloma

Mangiacavalli, S., Albani, G., Caravita, T., Cocito, F., Pascutto, C., Zappasodi, P., Bringhen, S., Palumbo, A., Cazzola, M. & Corso, A., Mar 2012, In : Leukemia and Lymphoma. 53, 3, p. 514-515 2 p.

Research output: Contribution to journalArticle

Severe intestinal vasculitis in a patient under treatment with bortezomib

Mangiacavalli, S., Zappasodi, P., Castagnola, C., Astori, C., Varettoni, M., Lazzarino, M. & Corso, A., 2007, In : Annals of Hematology. 86, 12, p. 923-924 2 p.

Research output: Contribution to journalArticle

Serum CA 125 is of clinical value in the staging and follow-up of patients with non-Hodgkin's lymphoma: Correlation with tumor parameters and disease activity

Lazzarino, M., Orlandi, E., Klersy, C., Astori, C., Brusamolino, E., Corso, A., Bellio, L., Gargantini, L., Morra, E. & Bernasconi, C., Feb 1 1998, In : Cancer. 82, 3, p. 576-582 7 p.

Research output: Contribution to journalArticle

Risk of second cancers in Waldenström macroglobulinemia

Varettoni, M., Tedeschi, A., Arcaini, L., Pascutto, C., Vismara, E., Orlandi, E., Ricci, F., Corso, A., Greco, A., Mangiacavalli, S., Lazzarino, M. & Morra, E., Feb 2012, In : Annals of Oncology. 23, 2, p. 411-415 5 p.

Research output: Contribution to journalArticle

Psychological care of caregivers, nurses and physicians: a study of a new approach

Abeni, M. S., Magni, M., Conte, M., Mangiacavalli, S., Pochintesta, L., Vicenzi, G., Ferretti, V. V., Pompa, A., Cocito, F., Klersy, C. & Corso, A., Feb 1 2014, In : Cancer Medicine. 3, 1, p. 101-110 10 p.

Research output: Contribution to journalArticle

Plateau phase in multiple myeloma: An end-point of conventional-dose chemotherapy

Corso, A., Nozza, A., Lazzarino, M., Klersy, C., Zappasodi, P., Arcaini, L. & Bernasconi, C., Apr 1999, In : Haematologica. 84, 4, p. 336-341 6 p.

Research output: Contribution to journalArticle

Pipobroman is safe and effective treatment for patients with essential thrombocythaemia at high risk of thrombosis

Passamonti, F., Malabarba, L., Orlandi, E., Pascutto, C., Brusamolino, E., Astori, C., Baratè, C., Canevari, A., Corso, A., Bernasconi, P., Cazzola, M. & Lazzarino, M., 2002, In : British Journal of Haematology. 116, 4, p. 855-861 7 p.

Research output: Contribution to journalArticle

Outcome of patients with refractory/relapsed aml salvaged with the mec (mitoxantrone etoposide cytarabine) regimen

Castagnola, C., Alessandrino, E. P., Pagnucco, G., Bernasconi, P., Lunghi, M., Colombo, A., Brusamolino, E., Bonfichi, M., Corso, A., Lazzarino, M. & Bernasconi, C., 2000, In : Blood. 96, 11 PART II

Research output: Contribution to journalArticle

Osteoprotegerin serum levels in multiple myeloma and MGUS patients compared with age- and sex-matched healthy controls [8]

Corso, A., Dovio, A., Rusconi, C., Sartori, M. L., Klersy, C., Varettoni, M., Mangiacavalli, S., Zappasodi, P., Ventura, M., Angeli, A. & Lazzarino, M., Sep 2004, In : Leukemia. 18, 9, p. 1555-1557 3 p.

Research output: Contribution to journalArticle

Neutrophil to lymphocyte ratio (NLR) improves the risk assessment of ISS staging in newly diagnosed MM patients treated upfront with novel agents

Romano, A., Parrinello, N. L., Consoli, M. L., Marchionni, L., Forte, S., Conticello, C., Pompa, A., Corso, A., Milone, G., Di Raimondo, F. & Borrello, I., Nov 22 2015, In : Annals of Hematology. 94, 11, p. 1875-1883 9 p.

Research output: Contribution to journalArticle

Multiple Myeloma Treatment in Real-world Clinical Practice: Results of a Prospective, Multinational, Noninterventional Study

EMMOS Investigators, Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple myeloma in younger patients: The role of age as prognostic factor

Corso, A., Klersy, C., Lazzarino, M. & Bernasconi, C., Feb 1998, In : Annals of Hematology. 76, 2, p. 67-72 6 p.

Research output: Contribution to journalArticle

Mucocutaneous paraneoplastic syndromes in hematologic malignancies

Zappasodi, P., Del Forno, C., Corso, A. & Lazzarino, M., Jan 2006, In : International Journal of Dermatology. 45, 1, p. 14-22 9 p.

Research output: Contribution to journalArticle

Monoclonal gammopathy of undetermined significance: A new proposal of workup

Mangiacavalli, S., Cocito, F., Pochintesta, L., Pascutto, C., Ferretti, V., Varettoni, M., Zappasodi, P., Pompa, A., Landini, B., Cazzola, M. & Corso, A., Oct 2013, In : European Journal of Haematology. 91, 4, p. 356-360 5 p.

Research output: Contribution to journalArticle

Modulation of all-trans retinoid acid pharmacokinetics in acute promyelocytic leukaemia by prolonged interferon-α therapy

Lazzarino, M., Corso, A., Regazzi, M. B., Iacona, I. & Bernasconi, C., 1995, In : British Journal of Haematology. 90, 4, p. 928-930 3 p.

Research output: Contribution to journalArticle

Modification of thrombomodulin plasma levels in refractory myeloma patients during treatment with thalidomide and dexamethasone

Corso, A., Lorenzi, A., Terulla, V., Airò, F., Varettoni, M., Mangiacavalli, S., Zappasodi, P., Rusconi, C. & Lazzarino, M., Sep 2004, In : Annals of Hematology. 83, 9, p. 588-591 4 p.

Research output: Contribution to journalArticle

Mitoxantrone with intermediate-or high-dose ara-c for refractory acute lymphoblastic leukemia and non-hodgkin's lymphoma

Morra, E., Lazzarino, M., Corso, A., Brusamolino, E., Pagnucco, G., Castagnola, C., Bernasconi, P., Santagostino, A., Livraghi, A. & Bernasconi, C., 1992, In : Leukemia and Lymphoma. 7, S2, p. 72-73 2 p.

Research output: Contribution to journalArticle

Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations

Girmenia, C., Cavo, M., Offidani, M., Scaglione, F., Corso, A., Di Raimondo, F., Musto, P., Petrucci, M. T. & Barosi, G., Jan 1 2019, (Accepted/In press) In : Blood Reviews.

Research output: Contribution to journalArticle

Management of acute promyelocytic leukemia relapse in the ATRA era

Castagnola, C., Lunghi, M., Corso, A., Tajana, M., Zappasodi, P., Dabusti, M., Lazzarino, M. & Bernasconi, C., Aug 1998, In : Haematologica. 83, 8, p. 714-717 4 p.

Research output: Contribution to journalArticle

Low efficacy of thalidomide in improving response after induction in multiple myeloma patients who are candidates for high-dose therapy

Corso, A., Mangiacavalli, S., Barbarano, L., Montalbetti, L., Mazzone, A., Fava, S., Varettoni, M., Zappasodi, P., Morra, E. & Lazzarino, M., Jul 2008, In : Leukemia Research. 32, 7, p. 1085-1090 6 p.

Research output: Contribution to journalArticle

Long-term outcome in relapsed and refractory multiple myeloma treated with thalidomide. Balancing efficacy and side-effects

Corso, A., Zappasodi, P., Barbarano, L., Petrucci, M. T., Palumbo, A., Caravita, T., Mangiacavalli, S., Cafro, A. M., Varettoni, M., Gay, F., Morra, E. & Lazzarino, M., Sep 2009, In : Leukemia Research. 33, 9

Research output: Contribution to journalArticle